194 related articles for article (PubMed ID: 22911631)
1. Long-term medical outcomes in survivors of extra-ocular retinoblastoma: the Memorial Sloan-Kettering Cancer Center (MSKCC) experience.
Friedman DN; Sklar CA; Oeffinger KC; Kernan NA; Khakoo Y; Marr BP; Wolden SL; Abramson DH; Dunkel IJ
Pediatr Blood Cancer; 2013 Apr; 60(4):694-9. PubMed ID: 22911631
[TBL] [Abstract][Full Text] [Related]
2. Chronic medical conditions in adult survivors of retinoblastoma: Results of the Retinoblastoma Survivor Study.
Friedman DN; Chou JF; Oeffinger KC; Kleinerman RA; Ford JS; Sklar CA; Li Y; McCabe MS; Robison LL; Marr BP; Abramson DH; Dunkel IJ
Cancer; 2016 Mar; 122(5):773-81. PubMed ID: 26755259
[TBL] [Abstract][Full Text] [Related]
3. Second malignant neoplasms in long-term survivors of osteosarcoma: Memorial Sloan-Kettering Cancer Center Experience.
Aung L; Gorlick RG; Shi W; Thaler H; Shorter NA; Healey JH; Huvos AG; Meyers PA
Cancer; 2002 Oct; 95(8):1728-34. PubMed ID: 12365021
[TBL] [Abstract][Full Text] [Related]
4. Treatment outcome of osteosarcoma after bilateral retinoblastoma: a retrospective study of eight cases.
Lee JA; Choi SY; Kang HJ; Lee JW; Kim H; Kim JH; Sung KW; Shin HY; Ahn HS; Park KD
Br J Ophthalmol; 2014 Oct; 98(10):1355-9. PubMed ID: 24795337
[TBL] [Abstract][Full Text] [Related]
5. Incidence of second cancers after radiotherapy and systemic chemotherapy in heritable retinoblastoma survivors: A report from the German reference center.
Temming P; Arendt M; Viehmann A; Eisele L; Le Guin CH; Schündeln MM; Biewald E; Astrahantseff K; Wieland R; Bornfeld N; Sauerwein W; Eggert A; Jöckel KH; Lohmann DR
Pediatr Blood Cancer; 2017 Jan; 64(1):71-80. PubMed ID: 27567086
[TBL] [Abstract][Full Text] [Related]
6. How Eye-Preserving Therapy Affects Long-Term Overall Survival in Heritable Retinoblastoma Survivors.
Temming P; Arendt M; Viehmann A; Eisele L; Le Guin CH; Schündeln MM; Biewald E; Mäusert J; Wieland R; Bornfeld N; Sauerwein W; Eggert A; Lohmann DR; Jöckel KH
J Clin Oncol; 2016 Sep; 34(26):3183-8. PubMed ID: 27382102
[TBL] [Abstract][Full Text] [Related]
7. Long-term complications in survivors of advanced stage neuroblastoma.
Laverdière C; Cheung NK; Kushner BH; Kramer K; Modak S; LaQuaglia MP; Wolden S; Ness KK; Gurney JG; Sklar CA
Pediatr Blood Cancer; 2005 Sep; 45(3):324-32. PubMed ID: 15714447
[TBL] [Abstract][Full Text] [Related]
8. Subsequent malignant neoplasms in the pediatric age in retinoblastoma survivors in Argentina.
Villanueva G; Sampor C; Moreno F; Alderete D; Moresco A; Pinto N; Szijan I; Schaiquevich P; Felice MS; Rose A; Zubizarreta P; Sgroi M; Fandiño A; Chantada G
Pediatr Blood Cancer; 2022 Aug; 69(8):e29710. PubMed ID: 35451226
[TBL] [Abstract][Full Text] [Related]
9. Subsequent malignancies and their effect on survival in patients with retinoblastoma.
Shinohara ET; DeWees T; Perkins SM
Pediatr Blood Cancer; 2014 Jan; 61(1):116-9. PubMed ID: 23918737
[TBL] [Abstract][Full Text] [Related]
10. Late sequela after treatment of childhood low-grade gliomas: a retrospective analysis of 69 long-term survivors treated between 1983 and 2003.
Benesch M; Lackner H; Sovinz P; Suppan E; Schwinger W; Eder HG; Dornbusch HJ; Moser A; Triebl-Roth K; Urban C
J Neurooncol; 2006 Jun; 78(2):199-205. PubMed ID: 16739030
[TBL] [Abstract][Full Text] [Related]
11. Strabismus in retinoblastoma survivors with long-term follow-up.
Fabian ID; Stacey AW; Naeem Z; Onadim Z; Chowdhury T; Duncan C; Sagoo MS; Reddy MA
J AAPOS; 2018 Aug; 22(4):276.e1-276.e7. PubMed ID: 30009948
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcome of centrally located low-grade glioma in children.
Terashima K; Chow K; Jones J; Ahern C; Jo E; Ellezam B; Paulino AC; Okcu MF; Su J; Adesina A; Mahajan A; Dauser R; Whitehead W; Lau C; Chintagumpala M
Cancer; 2013 Jul; 119(14):2630-8. PubMed ID: 23625612
[TBL] [Abstract][Full Text] [Related]
13. Long-term risk of subsequent cancer incidence among hereditary and nonhereditary retinoblastoma survivors.
Schonfeld SJ; Kleinerman RA; Abramson DH; Seddon JM; Tucker MA; Morton LM
Br J Cancer; 2021 Mar; 124(7):1312-1319. PubMed ID: 33473166
[TBL] [Abstract][Full Text] [Related]
14. Second malignant neoplasms in long-term survivors of childhood rhabdomyosarcoma.
Scaradavou A; Heller G; Sklar CA; Ren L; Ghavimi F
Cancer; 1995 Nov; 76(10):1860-7. PubMed ID: 8625059
[TBL] [Abstract][Full Text] [Related]
15. Risk of subsequent malignant neoplasms in long-term hereditary retinoblastoma survivors after chemotherapy and radiotherapy.
Wong JR; Morton LM; Tucker MA; Abramson DH; Seddon JM; Sampson JN; Kleinerman RA
J Clin Oncol; 2014 Oct; 32(29):3284-90. PubMed ID: 25185089
[TBL] [Abstract][Full Text] [Related]
16. Intensive multimodality therapy for patients with stage 4a metastatic retinoblastoma.
Dunkel IJ; Khakoo Y; Kernan NA; Gershon T; Gilheeney S; Lyden DC; Wolden SL; Orjuela M; Gardner SL; Abramson DH
Pediatr Blood Cancer; 2010 Jul; 55(1):55-9. PubMed ID: 20486171
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and toxicity of second-course ophthalmic artery chemosurgery for retinoblastoma.
Francis JH; Abramson DH; Gobin YP; Marr BP; Tendler I; Brodie SE; Dunkel IJ
Ophthalmology; 2015 May; 122(5):1016-22. PubMed ID: 25616769
[TBL] [Abstract][Full Text] [Related]
18. Risk of soft tissue sarcomas by individual subtype in survivors of hereditary retinoblastoma.
Kleinerman RA; Tucker MA; Abramson DH; Seddon JM; Tarone RE; Fraumeni JF
J Natl Cancer Inst; 2007 Jan; 99(1):24-31. PubMed ID: 17202110
[TBL] [Abstract][Full Text] [Related]
19. Long-term follow-up of children with retinoblastoma.
Nahum MP; Gdal-On M; Kuten A; Herzl G; Horovitz Y; Weyl Ben Arush M
Pediatr Hematol Oncol; 2001; 18(3):173-9. PubMed ID: 11293284
[TBL] [Abstract][Full Text] [Related]
20. Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up.
Marees T; Moll AC; Imhof SM; de Boer MR; Ringens PJ; van Leeuwen FE
J Natl Cancer Inst; 2008 Dec; 100(24):1771-9. PubMed ID: 19066271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
